- Home
- TOPS vs PMN Comparison
TOPS vs PMN Comparison
Compare TOPS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- PMN
- Stock Information
- Founded
- TOPS 2000
- PMN 2004
- Country
- TOPS Greece
- PMN Canada
- Employees
- TOPS N/A
- PMN N/A
- Industry
- TOPS Marine Transportation
- PMN Pharmaceuticals and Biotechnology
- Sector
- TOPS Consumer Discretionary
- PMN Health Care
- Exchange
- TOPS Nasdaq
- PMN Nasdaq
- Market Cap
- TOPS 31.1M
- PMN 33.7M
- IPO Year
- TOPS 2004
- PMN N/A
- Fundamental
- Price
- TOPS $6.78
- PMN $0.89
- Analyst Decision
- TOPS
- PMN
- Analyst Count
- TOPS 0
- PMN 0
- Target Price
- TOPS N/A
- PMN N/A
- AVG Volume (30 Days)
- TOPS 15.3K
- PMN 53.0K
- Earning Date
- TOPS 08-09-2024
- PMN 11-14-2024
- Dividend Yield
- TOPS N/A
- PMN N/A
- EPS Growth
- TOPS N/A
- PMN N/A
- EPS
- TOPS N/A
- PMN N/A
- Revenue
- TOPS $83,870,000.00
- PMN N/A
- Revenue This Year
- TOPS $7.10
- PMN N/A
- Revenue Next Year
- TOPS $6.54
- PMN N/A
- P/E Ratio
- TOPS N/A
- PMN N/A
- Revenue Growth
- TOPS 1.10
- PMN N/A
- 52 Week Low
- TOPS $5.30
- PMN $0.87
- 52 Week High
- TOPS $14.94
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- TOPS 50.38
- PMN 40.96
- Support Level
- TOPS $6.70
- PMN $0.88
- Resistance Level
- TOPS $7.60
- PMN $0.96
- Average True Range (ATR)
- TOPS 0.40
- PMN 0.07
- MACD
- TOPS 0.09
- PMN -0.01
- Stochastic Oscillator
- TOPS 55.79
- PMN 4.04
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.